| Literature DB >> 33649239 |
Ran Brosh1, Jon M Laurent1, Raquel Ordoñez1, Emily Huang1, Megan S Hogan1, Angela M Hitchcock1, Leslie A Mitchell1, Sudarshan Pinglay1, John A Cadley1, Raven D Luther1, David M Truong1, Jef D Boeke2,3,4, Matthew T Maurano1,5.
Abstract
Routine rewriting of loci associated with human traits and diseases would facilitate their functional analysis. However, existing DNA integration approaches are limited in terms of scalability and portability across genomic loci and cellular contexts. We describe Big-IN, a versatile platform for targeted integration of large DNAs into mammalian cells. CRISPR/Cas9-mediated targeting of a landing pad enables subsequent recombinase-mediated delivery of variant payloads and efficient positive/negative selection for correct clones in mammalian stem cells. We demonstrate integration of constructs up to 143 kb, and an approach for one-step scarless delivery. We developed a staged pipeline combining PCR genotyping and targeted capture sequencing for economical and comprehensive verification of engineered stem cells. Our approach should enable combinatorial interrogation of genomic functional elements and systematic locus-scale analysis of genome function.Entities:
Keywords: genome engineering; genome writing; regulatory genomics; stem cells; synthetic biology
Year: 2021 PMID: 33649239 DOI: 10.1073/pnas.2023952118
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205